FDA Approves Pain Drug for Opiate-Tolerant Patients
Links shared publicly online about this topic.
- 1,407total visits
FDA Approves Pain Drug for Opiate-Tolerant Patients
View full resource at chronicfatigue.about.com
Tags: Pain Medication, Pain, Drug, FDA
Most Recently Shared on February 4, 2010 at 11:34 am By:
FDA Approves Pain Drug for Opiate-Tolerant Patients http://bit.ly/dmxFpy
Chronic pain: Watch out before accepting diagnosis and treatment
sciencedaily.com — “Experts argue that patients should be diligent in demanding proof of safety and benefit before beginning chronic pain treatment, as some medications have little evidence that they alleviate conditions for which they are prescribed. The experts dispel myths surrounding chronic Lyme disease, using it as an example of why patients ensure that diagnostic and treatment tools are approved by the FDA and not just recommended by other patients and physicians.” View full resource at sciencedaily.com
Most Recently Shared on September 10, 2011 at 1:25 pm By:
Chronic pain: Watch out before accepting diagnosis and treatment: http://t.co/JSxHKqQ via @AddThis
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 4:51 pm By:
New nasal spray to treat pain in cancer patients is approved by the #FDA http://bit.ly/k9MyZr
FDA Okays Nasal Spray for Ca Pain - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 1:45 pm By:
FDA Okays Nasal Spray for Ca Pain: WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of... http://bit.ly/mpdinQ
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:27 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/l97juH
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:16 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/j6KrSw
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients
medicalnewstoday.com — “Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Lazanda® (fentanyl) nasal spray for the managem” View full resource at medicalnewstoday.com
Most Recently Shared on July 1, 2011 at 8:05 am By:
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients http://mnt.to/3XSk
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
drugs.com — “Lazanda (fentanyl) nasal spray is used to treat breakthrough pain in cancer patients. Includes Lazanda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 1, 2011 at 1:08 am By:
Drugs and Devices OW OW Health
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Pati... http://bit.ly/mxmtJE #drug
DC Walk to Celebrate New Lupus Drug
disabled-world.com — “Approved by the FDA BENLYSTA and GlaxoSmithKline represents relief for unrelenting pain faced by lupus patients whose disease still lacks a cure” View full resource at disabled-world.com
Most Recently Shared on March 28, 2011 at 8:17 pm By:
Disabled World Health Advocate and Health News
DC Walk to Celebrate New Lupus Drug http://ff.im/-zWrdb
Generic Drug Alert: FDA Approves Generic Version of Epilepsy Drug Neurontin | MyHealthCafe.com
myhealthcafe.com — “Quick generic drug approval bulletin for today. If you have a family member or other loved suffers from epilepsy or pain caused by shingles, the U.S. Food and” View full resource at myhealthcafe.com
Most Recently Shared on March 1, 2011 at 8:57 pm By:
Great news for patients! RT @myhealthcafe: #FDA approves generic for epilepsy drug Neurontin. http://myhealthcafe.com/?p=3863 #CHT_Health
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
drugs.com — “Abstral (fentanyl) is used for the treatment of breakthrough pain in cancer patients. Includes Abstral side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 5:14 am By:
Drugs and Devices OW OW Health
FDA Approval for Abstral (Fentanyl) Sublingual Tablets: Uppsala, January 10, 2011 - Orexo AB announces tod... http://bit.ly/gmQwZy #drug
FDA approves Abstral drug for treatment of breakthrough pain in cancer patients
news-medical.net — “Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration for Abstral. Abstral is licensed for the treatment of breakthrough pain in cancer patients, 18 years of age and older, who are already receiving, and are tolerant to, opioid analgesics for their underlying persistent cancer pain.” View full resource at news-medical.net
Most Recently Shared on January 10, 2011 at 9:15 am By:
FDA approves Abstral drug for treatment of breakthrough pain in cancer patients: Orexo AB announces today that i... http://bit.ly/ffwbDf
FDA Approves Opioid Analgesic To Help Cancer Patients Manage Pain
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer. Fentanyl immediate-release transmucosal medications are” View full resource at medicalnewstoday.com
Most Recently Shared on January 8, 2011 at 2:05 pm By:
MNT Drug Approvals Health News
FDA Approves Opioid Analgesic To Help Cancer Patients Manage Pain http://mnt.to/3PNf #regulatory
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery - - Drug Topics
drugtopics.modernmedicine.com — “Bromfenac ophthalmic solution (Bromday, ISTA Pharmaceuticals) 0.09% has been granted FDA approval as a once-daily prescription eyedrop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 21, 2010 at 2:27 pm By:
Drugs and Devices OW OW Health
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery: Br... http://bit.ly/cO6qbt #drug
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 12:10 am By:
Drugs and Devices OW OW Health
ISTA Pharmaceuticals Receives FDA Approval for Bromday: IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- IST... http://bit.ly/a2xJ9h #drug
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.Vivitrol is an extended-” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2010 at 4:21 pm By:
MNT Alcohol / Addict Health News
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients http://mnt.to/3L8Z #alcohol #addiction
Advertisement
